Strategic shareholdings aimed at developing and strengthening business and operational relationships
First written in FY2016. 3 of 11 entries say "Advanced", first in FY2025. Latest entry: FY2026.
The whole theme swung hardest in 2019: 17 of 136 companies on the "Worse" side.
- FY2026Partial sale of cross-shareholdings and increase in their carrying valueAnnual report
「(Issues whose number of shares decreased during the fiscal year) Shares other than unlisted shares 3 ¥4,594 million」
Cross-shareholdings comprised 18 listed or other issues, and 3 issues were sold. Meanwhile, the carrying amount increased from ¥28,189 million in the previous fiscal year to ¥32,004 million, mainly due to higher share prices. - FY2025AdvancedAnnual report
「As a basic policy, we do not hold cross-shareholdings unless they are deemed to contribute to the stability of our group's business and the enhancement of corporate value through the development and expansion of trading and business alliance relationships. ...Unlisted shares 11 ¥361 million ...Shares other than unlisted shares 19 ¥28,189 million」
Cross-shareholdings comprised 30 issues with a carrying amount of ¥28,550 million, down from 31 issues and ¥33,755 million in the previous fiscal year in both number of issues and balance. The company also disclosed quantitative and qualitative assessments by the Board of Directors. - FY2024RaisedAnnual report
「In addition, toward achieving management that is conscious of the cost of capital and share prices, we are working to improve capital efficiency by creating sustainable value as a drug discovery and research and development company, while defining our desired state as financial conditions comprising ROE of at least 8%, PBR of at least 1x, and cross-shareholdings of no more than 10% of net assets.」
The company newly specified a quantitative target of cross-shareholdings representing no more than 10% of net assets as its desired state. Cross-shareholdings had declined to 31 issues totaling ¥33,755 million. - FY2022Decrease in the number and balance of holdingsAnnual report
「As a basic policy, we do not hold cross-shareholdings unless they are deemed to contribute to the stability of our group's business and the enhancement of corporate value through the development and expansion of trading and business alliance relationships.」
Cross-shareholdings comprised 13 unlisted issues totaling ¥4,036 million and 26 listed or other issues totaling ¥36,491 million, bringing the total carrying amount down to ¥40,527 million. The policy on holding purposes and validity assessments by the Board of Directors has been maintained. - FY2020Increase in the balance of holdings and new investmentsAnnual report
「As a basic policy, we do not hold cross-shareholdings unless they are deemed to contribute to the stability of our group's business and the enhancement of corporate value through the development and expansion of trading and business alliance relationships. ...Unlisted shares 13 ¥3,623 million ...Shares other than unlisted shares 27 ¥68,553 million ...Investment for medium- to long-term business alliance relationships」
Cross-shareholdings comprised 40 issues with a total carrying amount of ¥72,176 million. The company also invested ¥3,323 million in unlisted shares for a medium- to long-term business alliance. - FY2019Decrease in the number and balance of holdings and change in purposeAnnual report
「As a basic policy, we do not hold cross-shareholdings unless they are deemed to contribute to the stability of our group's business and the enhancement of corporate value through the development and expansion of trading and business alliance relationships.」
Cross-shareholdings comprised 40 issues with a balance-sheet carrying amount of ¥60,313 million, down from 42 issues and ¥61,304 million in the previous fiscal year. The purpose of holding shares in Alteogen, Inc. was also changed to pure investment. - FY2018Increase in the balance of holdingsAnnual report
「a. Number of issues and total balance-sheet carrying amount of investment shares held for purposes other than pure investment 42 issues ¥61,304 million」
The purpose of holding shares, namely to develop and strengthen business and trading relationships, was maintained, and the number of holdings remained unchanged at 42, while the carrying amount increased from ¥42,088 million in the previous fiscal year to ¥61,304 million. - FY2017Decrease in the number and balance of holdingsAnnual report
「Number of issues and total balance-sheet carrying amount of investment shares held for purposes other than pure investment: 42 issues, ¥42,088 million」
Although the policy of holding shares to develop and strengthen business and trading relationships has been maintained, the number of holdings and their carrying amount decreased from 44 issues and ¥54,815 million in the previous fiscal year. - FY2016First statedAnnual report
「Purpose of holding: developing and strengthening business and trading relationships」
The company holds shares in 44 companies for purposes other than pure investment, with a total balance-sheet carrying amount of ¥54,815 million.